Rhythm Pharmaceuticals shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Rhythm Pharmaceuticals (RYTM) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Rhythm Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Rhythm Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Rhythm Pharmaceuticals by Ubs Global Asset Management Americas
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $9.0M | 207k | 43.33 |
2023-12-31 | $9.7M | 210k | 45.97 |
2023-09-30 | $7.7M | 337k | 22.93 |
2023-06-30 | $3.7M | 206k | 17.84 |
2023-03-31 | $3.7M | 206k | 17.84 |
2022-12-31 | $1.2M | 42k | 29.12 |
2022-09-30 | $734k | 30k | 24.50 |
2022-06-30 | $228k | 55k | 4.15 |
2022-03-31 | $339k | 29k | 11.52 |
2021-12-31 | $294k | 29k | 9.98 |
2021-09-30 | $329k | 25k | 13.06 |
2021-06-30 | $494k | 25k | 19.58 |
2021-03-31 | $223k | 11k | 21.27 |
2020-12-31 | $693k | 32k | 21.67 |
2020-09-30 | $693k | 32k | 21.67 |
2020-06-30 | $425k | 19k | 22.30 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas